
| Pair Name | Radix ranunculus temate saponins, Paclitaxel | ||
| Phytochemical Name | Radix ranunculus temate saponins (PubChem CID: / ) | ||
| Anticancer drug Name | Paclitaxel (PubChem CID: 36314 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Radix ranunculus temate saponins, Paclitaxel | |||
| Disease Info | [ICD-11: 2C73] | Ovarian cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | COL3A1 | hsa1281 |
| In Vitro Model | A2780 | Ovarian endometrioid adenocarcinoma | Homo sapiens (Human) | CVCL_0134 |
| OVCAR-3 | High grade ovarian serous adenocarcinoma | Homo sapiens (Human) | CVCL_0465 | |
| SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens (Human) | CVCL_0532 | |
| In Vivo Model | A2780 cells (1×10⁶) were injected subcutaneously into the back of six-week-old BALB/c nu/nu female mice. | |||
| Result | Combination of Taxol and RRTS may be a novel treatment strategy for patients with TR ovarian cancer. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Radix ranunculus temate saponins sensitizes ovarian cancer to Taxol via upregulation of miR-let-7b. Exp Ther Med. 2022 May;23(5):315. doi: 10.3892/etm.2022.11244. | Click |